Molecular typing is based on molecular genetic screening and isn't but routinely available. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-sixty seven may very https://stewartd197aiq4.livebloggs.com/profile